7 Clinics · Kerala & Tamil Nadu · +91 80860 00608 · help@dermavue.com
Clinical White Paper · Physician Review

Fat Burners vs GLP-1 Therapy: A Physician's Honest Comparison

A calm, evidence-first comparison of thermogenic capsules, garcinia, apple cider vinegar, keto pills, Ayurvedic slimming blends and prescription GLP-1 therapy. Written by the DermaVue medical team using only published trial data.

Criterion Thermogenic Fat Burners OTC Weight Loss Tablets Ayurvedic Slimming Prescription GLP-1 Therapy
Typical body weight loss 1 to 3 percent over 12 weeks (mostly water and caffeine effect) Variable, often under 2 percent No reliable data 14.9 to 22.5 percent over 60 to 72 weeks
Peer-reviewed RCTs in obesity Few, mostly small and short Few Effectively none for branded blends Multiple landmark trials in NEJM, JAMA, Lancet
Cardiovascular benefit shown No No No Yes (SELECT, 20 percent MACE reduction)
Kidney benefit shown No No No Yes (FLOW, 24 percent kidney event reduction)
Regulatory status in India OTC, lightly regulated OTC or grey market OTC, AYUSH framework Prescription only, physician supervised
Monthly cost in India (2026) INR 1,500 to 4,000 INR 800 to 3,500 INR 1,200 to 3,000 INR 8,000 to 25,000 depending on agent and dose
Physician supervision Not required Not required Not required Required
Documented harm signals Liver, cardiac, stimulant Liver, cardiac, undeclared ingredients Heavy metal, contamination Nausea and reflux, dose-dependent and well characterised
Quick answer. Most over-the-counter fat burners sold in India have no peer-reviewed evidence of meaningful weight loss, and several carry documented liver and cardiac risks. Prescription GLP-1 therapy, by contrast, has produced 14.9 to 22.5 percent average body weight reduction across large randomised trials. The honest answer: one category has marketing, the other has data.
DermaVue Clinics medical team is asked weekly about fat burners, garcinia cambogia capsules, keto pills, apple cider vinegar gummies and ayurvedic slimming formulations. The reality is sobering. The largest GLP-1 trial in obesity, SURMOUNT-1 published by Jastreboff and colleagues in NEJM 2022, recorded an average 22.5 percent reduction in body weight at 72 weeks for tirzepatide 15 mg. No over-the-counter fat burner sold in India has produced anything close to that effect in a randomised trial. Several have produced documented liver injury, cardiac arrhythmia and unregulated stimulant exposure. This page sets the two categories side by side using only published evidence.

What Indian Patients Are Actually Taking

In a typical week at our clinics, the products patients bring in fall into five categories:

  1. Thermogenic fat burners. Capsules stacking caffeine, green tea catechins, L-carnitine, yohimbine and sometimes synephrine. Sold by gym brands and online sellers.
  2. Garcinia cambogia. Marketed as a hydroxycitric acid supplement that blocks fat synthesis.
  3. Apple cider vinegar gummies. Often combined with B vitamins and sold as a metabolic aid.
  4. Keto pills and exogenous ketones. Capsules containing beta-hydroxybutyrate salts marketed as fat burners that put the body into ketosis without diet.
  5. Ayurvedic slimming formulations. Multi-herb proprietary blends sold under wellness branding, often with claims about agni, ama and metabolic balance.
  6. OTC phentermine analogs and unregulated stimulant imports. Quietly available through some online channels, never legally dispensed.

These are real products real patients are spending real money on. We do not dismiss them with a wave. We look at the evidence.

The Evidence Problem

Garcinia cambogia

Garcinia is the most studied of the lot, and the evidence is unimpressive. Multiple randomised controlled trials and at least two systematic reviews have found that garcinia produces, at best, a fraction of a kilogram more weight loss than placebo over twelve weeks, an effect that does not survive longer trials. The hydroxycitric acid mechanism is plausible in cell culture and breaks down in human physiology.

When a patient asks if garcinia "works", the honest physician answer is: not in any way that would matter to your health.

Green tea extract and thermogenics

Green tea catechins, particularly EGCG, do produce a small thermogenic effect. The published meta-analyses in healthy adults converge on a 1 to 2 percent body weight effect over three to six months, almost always confounded by the caffeine in the same capsule. That is a 0.6 to 1.2 kg effect on a 60 kg woman. Not nothing, but not the result the marketing implies, and the trade-off in side effects is significant.

Apple cider vinegar

The peer-reviewed evidence on apple cider vinegar for weight loss consists of a small handful of short trials with modest effects on appetite and post-meal glucose. The total body weight effect, where measurable, sits below 1 to 2 kg over three months. ACV is not dangerous in moderation. It is also not a treatment for obesity.

Keto pills and exogenous ketones

Exogenous ketone supplements raise blood ketone levels for a few hours after a dose. They do not put the body into a fat-burning state in any meaningful sense, and they do not produce weight loss in trials. The keto pill category is one of the clearest examples of marketing language outrunning physiology.

Ayurvedic slimming formulations

Ayurvedic medicine has a long and serious tradition. The branded "slimming" capsules sold under Ayurvedic labels in 2026, however, are usually proprietary blends with no individual ingredient trial data and no oversight on dose, batch consistency or contamination. Heavy metal contamination has been documented in independent assays of unregulated Ayurvedic preparations. As a physician, the absence of data is the problem, not the tradition.

The Safety Problem

The conversation cannot stop at efficacy. Several of these categories carry documented harm.

  • Liver injury. Both garcinia cambogia and high-dose green tea extract have been linked to acute liver injury in case reports collected by drug-induced liver injury registries. The cases are uncommon, and they are real.
  • Cardiac events. Caffeine-yohimbine-synephrine stacks raise heart rate and blood pressure. Emergency department reports tied to thermogenic fat burners include tachyarrhythmia, hypertensive episodes and, in rare cases, more serious events.
  • Thyroid suppression and unregulated thyroid hormone. Some grey-market "metabolism boosters" sold online contain undeclared thyroid hormone or its analogues. Patients present months later with iatrogenic thyrotoxicosis.
  • Unregulated stimulant imports. OTC phentermine analogs and DMAA-containing products are illegal in most jurisdictions and continue to surface in online sales.

A medication a physician would not prescribe is not made safer by being sold without a prescription. It is made less safe.

What Actually Works: The GLP-1 Data

The contrast with prescription GLP-1 therapy is stark. We are not comparing marketing to marketing. We are comparing marketing to data.

STEP 1

Wilding et al., NEJM 2021;384:989

Semaglutide 2.4 mg weekly produced an average 14.9 percent reduction in body weight at 68 weeks in adults with obesity, against 2.4 percent for placebo. Mean baseline weight roughly 105 kg.

SURMOUNT-1

Jastreboff et al., NEJM 2022;387:205

Tirzepatide 15 mg weekly produced an average 22.5 percent reduction in body weight at 72 weeks in adults with obesity, against 3.1 percent for placebo.

SELECT

Lincoff et al., NEJM 2023;389:2221

Semaglutide 2.4 mg reduced major adverse cardiovascular events by 20 percent over a median 39.8 months in adults with established cardiovascular disease and overweight or obesity.

FLOW

Perkovic et al., NEJM 2024;391:109

Semaglutide 1 mg reduced major kidney disease events by 24 percent in adults with type 2 diabetes and chronic kidney disease.

These are not supplement-grade studies. These are large, randomised, placebo-controlled trials in major journals. The effect sizes are an order of magnitude greater than anything the supplement category has produced, and they come with cardiovascular and kidney benefit as a bonus.

March 2026 generic update. Semaglutide generics are entering the Indian market. Cost is coming down. See our latest briefing on generic GLP-1 options in India.

Side by Side: The Data Gap Is Real

The table at the top of this page summarises the comparison in one view. The cost gap is real. The data gap is also real. A patient paying INR 3,000 a month for an unproven supplement is not saving money. She is paying for a result she will not get.

Can I Combine a Fat Burner with My GLP-1?

No. We are clear about this in clinic. Stacking a stimulant fat burner on top of GLP-1 therapy is a bad idea for several reasons:

  • GLP-1 medications slow gastric emptying, which can prolong stimulant absorption and amplify cardiac side effects.
  • Both categories suppress appetite. The combined effect can drop daily intake low enough to cause dehydration, electrolyte disturbance and muscle loss.
  • The nausea profile of GLP-1 therapy is harder to interpret when a stimulant is also on board. We need a clean picture to titrate safely.

If you are on GLP-1 therapy, the rule is simple. The supplement comes off.

The Honest Physician Recommendation

If a patient walks into our clinic and asks which category they should choose, the answer depends on who they are.

  • A 25-year-old with a BMI of 24 who wants to lose 3 kg before a wedding does not need GLP-1 therapy and does not need a fat burner. She needs a structured eight-week protocol of protein, training and sleep.
  • A 38-year-old with a BMI of 31, central obesity and a family history of diabetes does not need a fat burner. She needs a medical weight loss assessment and, if eligible, GLP-1 therapy under physician supervision.
  • A 52-year-old man with a BMI of 33 and established cardiovascular disease does not need a fat burner. He needs the SELECT trial result, which means semaglutide under cardiology coordination.
"The fat burner category survives because it is sold to people who are not given an honest assessment first. The job of a clinic is to provide that assessment."

To go deeper on the medicines themselves, see the GLP-1 medications in India briefing. To check fit, start with am I eligible for medical weight loss?. For the full trial evidence library, see the DermaVue clinical evidence library.

Frequently Asked Questions

Not in any way that should change your decision. Multiple randomised controlled trials and systematic reviews have found that garcinia produces, at most, a fraction of a kilogram more weight loss than placebo over twelve weeks, and the effect does not hold up in longer trials. There are also documented case reports of acute liver injury linked to garcinia preparations. The honest physician answer is no.

Green tea catechins and caffeine produce a small measurable thermogenic effect, in the range of 1 to 2 percent of body weight over several months. That translates to under 1 kg for most patients, almost always confounded by caffeine, and the higher-dose extracts have been linked to liver injury in rare cases. It is not a serious tool for clinical obesity.

No. Exogenous ketone supplements raise blood ketone levels for a few hours but do not produce weight loss in trials and do not put the body into a meaningful fat-burning state on their own. The keto pill category is one of the clearest gaps between marketing language and physiology.

The traditional Ayurvedic system is serious and respected. Branded proprietary slimming capsules sold under Ayurvedic labels are a different question. They typically lack individual ingredient trial data, lack dose standardisation and have, in independent assays, sometimes shown heavy metal contamination. As a physician, the absence of data is the issue.

The published evidence on apple cider vinegar for weight loss is small, short and modest. Where measurable, the total body weight effect over three months sits below 1 to 2 kg. ACV is not dangerous in normal amounts and is also not a treatment for obesity. It is not the answer.

For an eligible patient under physician supervision, yes. Semaglutide and tirzepatide have well-characterised, dose-dependent side effects (mostly nausea, mild reflux and constipation) that are managed by careful titration. The OTC fat burner category, by contrast, includes documented liver injury, cardiac events and undeclared ingredients. Risk you can see and manage is safer than risk you cannot.

GLP-1 therapy in India in 2026 typically runs INR 8,000 to 25,000 per month depending on the agent and dose. OTC fat burners run INR 1,500 to 4,000 per month. The price gap is real. The result gap is also real. A 22.5 percent body weight reduction at 72 weeks is not on offer in the supplement aisle at any price.

No. Stacking stimulant fat burners on GLP-1 therapy can prolong stimulant absorption, increase cardiac side effects and drive intake low enough to cause dehydration and muscle loss. If you are on GLP-1 therapy, the supplement comes off. We are firm on this in clinic.

Phentermine is a prescription stimulant in jurisdictions where it remains approved, and unregulated online sources are not safe. Analogues sold without a prescription have been linked to cardiac events. We do not recommend OTC phentermine or its analogues under any circumstances.

Get a Real Assessment, Not a Sales Pitch

Free 10-minute WhatsApp triage with a DermaVue physician. No supplements sold.